| Date Filed | Type | Description |
| 08/22/2023 |
4
| Weisenhoff Michael (Assistant Controller) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 4,000 shares
@ $0 |
|
| 08/22/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/21/2023 |
4
| Doucot Charles M (Executive Vice President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Sold 12,700 shares
@ $4.66, valued at
$59.2k
|
|
| 08/21/2023 |
4
| Hullinger Brian (President & CEO) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 100,000 options to buy
@ $4.64, valued at
$464k
Granted 200,000 options to buy
@ $4.64, valued at
$928k
|
|
| 08/21/2023 |
4
| Reynolds Andrew (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 14,000 shares
@ $0 |
|
| 08/21/2023 |
4
| Davis Robyn C (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 14,000 shares
@ $0 |
|
| 08/21/2023 |
4
| Kamin Peter (10% Owner) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 14,000 shares
@ $0 |
|
| 08/21/2023 |
4
| NEVIN DARIUS G (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 14,000 shares
@ $0 |
|
| 08/21/2023 |
8-K
| Appointed a new director|
Docs:
|
"NON QUALIFIED STOCK OPTION AGREEMENT NON QUALIFIED STOCK OPTION AGREEMENT made this 17 th day of August, 2023 between PSYCHEMEDICS CORPORATION, a Delaware corporation , and Brian Hullinger, an employee or independent contractor of the Corporation or one or more of its subsidiaries . The Corporation desires, by affording the Optionee an opportunity to purchase shares of its Common Stock, $.005 par value , as hereinafter provided, and as an inducement material to the Optionee’ s entering into employment as Chief Executive Officer of the Corporation, in accordance with the terms of the Offer of Employment between Optionee and the Corporation dated July 12, 2023 NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth and for other good and valuable consideration, the par...",
"NON QUALIFIED STOCK OPTION AGREEMENT",
"Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635 ACTON, Mass., Aug. 18, 2023 -- Psychemedics Corporation , the world’s largest provider of hair testing for drugs of abuse, announced the grant of inducement awards to its newly appointed President and Chief Executive Officer, Brian Hullinger, upon his entering into employment with the Company in accordance with Nasdaq Listing Rule 5635. Mr. Hullinger received an inducement grant option to purchase up to 300,000 shares of common stock. The inducement awards were granted on August 17, 2023, Mr. Hullinger’s hire date as the Chief Executive Officer, and also the date on which he was elected to the Psychemedics Corporation Board of Directors. The options have a ten-year term and an exercise price of $4.65 per shar..." |
|
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
3
| Hullinger Brian (President & CEO) has filed a Form 3 on PSYCHEMEDICS CORP |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/11/2023 |
8-K
| Quarterly results |
| 07/31/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/21/2023 |
8-K
| Quarterly results |
| 07/21/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 07/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 07/14/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/24/2023 |
4
| SCHAFFER MICHAEL I (VP of Laboratory Operations) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 375 shares
@ $4.93, valued at
$1.8k
|
|
| 05/24/2023 |
4
| Doucot Charles M (Executive Vice President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 825 shares
@ $4.93, valued at
$4.1k
|
|
| 05/24/2023 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,500 shares
@ $4.93, valued at
$7.4k
|
|
| 05/16/2023 |
4
| Doucot Charles M (Executive Vice President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 900 shares
@ $4.87, valued at
$4.4k
|
|
| 05/16/2023 |
4
| SCHAFFER MICHAEL I (VP of Laboratory Operations) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 337 shares
@ $4.87, valued at
$1.6k
|
|
| 05/16/2023 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,725 shares
@ $4.87, valued at
$8.4k
|
|
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 03/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/21/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G/A
| KUBACKI RAYMOND C JR reports a 6.5% stake in Psychemedics Corporation |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/30/2022 |
8-K
| Quarterly results |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|